Qingdao Sanbai Shuo Health Technology Co., Ltd. 2025 Annual Report on the Deposit, Management, and Use of Raised Funds

Securities Code: 001300 Securities Abbreviation: Sanbai Shuo Announcement Number: 2026-017 Qingdao Sanbai Shuo Health Technology Co., Ltd. 2025 Annual Report on the Deposit, Management, and Use of Raised Funds The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions. Qingdao Sanbai Shuo Health Technology Co., Ltd. (hereinafter referred to as the "Company") has prepared this special report on the deposit, management, and use of raised funds for 2025 in accordance with the "Supervision Regulations for the Raising of Funds by Listed Companies" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Standardized Operation of Main Board Listed Companies" issued by the China Securities Regulatory Commission. I. Basic Situation of Raised Funds (I) Situation of Raised Funds Received As approved by the China Securities Regulatory Commission's "Approval on the Initial Public Offering of Shares by Qingdao Sanbai Shuo Health Technology Co., Ltd." (Securities Regulatory Permit [2022] No. 2054), Qingdao Sanbai Shuo Health Technology Co., Ltd. publicly issued 60,943,979 ordinary shares of RMB (A shares) to the public, with a par value of RMB 1 per share. The issue price was RMB 11.17 per share, and the total amount of raised funds was RMB 680,744,245.43. After deducting issuance expenses of RMB 70,090,350.29, the net amount of raised funds was RMB 610,653,895.14. As of October 14, 2022, the net amount of raised funds of RMB 610,653,895.14 had been fully received. The receipt of these raised funds was verified by the "Capital Verification Report" (Hoxinyan Zi [2022] No. 000046) issued by Hoxinyan Certified Public Accountants (Special General Partnership). The Company has opened special accounts to deposit these raised funds. (II) Use and Balance of Raised Funds in 2025 The use of raised funds in special accounts in 2025 and the balance as of December 31, 2025, are as follows: Unit: RMB Balance of Raised Funds in Special Account as of December 31, 2024 Add: Principal of idle raised funds invested in wealth management products at the beginning of the period Add: Income from redemption of temporarily idle raised funds invested in wealth management products Add: Net interest income from raised funds in special accounts after deducting handling fees Of which: Interest income from raised funds Handling fee expenses Less: Raised funds invested in projects during the year Less: Surplus raised funds from projects permanently replenished to working capital Total balance of raised funds as of December 31, 2025 Less: Principal of idle raised funds invested in wealth management products at the end of the period Less: Replenishment of working capital Balance of Raised Funds in Special Account as of December 31, 2025 5,858,145.22 457,000,000.00 8,530,787.90 144,101.95 144,101.95 471,533,035.07 470,000,000.00 1,533,035.07 II. Deposit and Management of Raised Funds To standardize the management and use of raised funds, improve the efficiency and effectiveness of fund utilization, and protect the rights and interests of investors, the Company has formulated the "Qingdao Sanbai Shuo Health Technology Co., Ltd. Raised Funds Management System" (hereinafter referred to as the "Raised Funds Management System") in accordance with the "Company Law of the People's Republic of China," the "Securities Law of the People's Republic of China," the "Stock Listing Rules of the Shenzhen Stock Exchange," and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," as well as other relevant laws, regulations, and normative documents, taking into account the Company's actual situation. In accordance with the "Raised Funds Management System," the Company implements special account deposit and dedicated use of raised funds. (I) Management of Raised Funds In October 2022, the Company and China Securities Co., Ltd. signed "Tripartite Custody Agreements for Raised Funds" with Industrial Bank Co., Ltd. Qingdao Chengyang Branch, Bank of Communications Co., Ltd. Qingdao Chengyang Branch, China CITIC Bank Co., Ltd. Qingdao Chengyang Branch, Huaxia Bank Co., Ltd. Qingdao Chengyang Branch, and Shanghai Pudong Development Bank Co., Ltd. Qingdao Chengyang Branch. The special account of Industrial Bank Co., Ltd. Qingdao Chengyang Branch (Account No. 3803027329200736708) was closed on December 3, 2024, and the special account of Shanghai Pudong Development Bank Co., Ltd. Qingdao Chengyang Branch (Account No. 69030078801300002561) was closed on December 10, 2024. (II) Situation of Raised Funds in Special Accounts As of December 31, 2025, the Company has closed 2 special accounts for raised funds. The opening banks and deposit status of the raised funds special accounts are as follows: Opening Bank Bank Account Unit: RMB Balance of Raised Funds in Special Account Industrial Bank Co., Ltd. Qingdao Chengyang Branch Business Department 3803027329200736708 Closed Bank of Communications Co., Ltd. Qingdao Chengyang Branch 372005580013002576916 22.59 China CITIC Bank Co., Ltd. Qingdao Chengyang Branch 8110601014401508757 62.59 Huaxia Bank Co., Ltd. Qingdao Chengyang Branch 12058000001901372 68.12 Shanghai Pudong Development Bank Co., Ltd. Qingdao Chengyang Branch 69030078801300002561 Closed Total 153.30 Note: As of December 31, 2025, the balance of raised funds in special accounts is RMB 153.30 million. The balance in the cash management account for raised funds is RMB 47,000.00 million, and the total balance of raised funds is RMB 47,153.30 million. III. Actual Use of Raised Funds in the Current Year (I) Use of Raised Funds for Investment Projects As of December 31, 2025, the Company has cumulatively invested RMB 14,143.05 million in raised funds for investment projects. The utilization situation is detailed in Appendix 1, "Comparison Table of Raised Funds Utilization." (II) Prior Investment and Replacement of Raised Funds for Investment Projects During the reporting period, the Company had no prior investment or replacement of raised funds for investment projects. (III) Temporary Use of Temporarily Idle Raised Funds to Supplement Working Capital On April 25, 2025, the Company held its 8th meeting of the Second Board of Directors, which reviewed and approved the "Proposal on Using Part of the Temporarily Idle Raised Funds to Temporarily Supplement Working Capital." It was agreed that, under the premise of ensuring the funding needs of the investment projects, an amount not exceeding RMB 150 million (inclusive) of temporarily idle raised funds would be used to temporarily supplement working capital, limited to production and operation related to the main business. The usage period is 12 months from the date of the Board of Directors' approval, and the amount can be rolled over within the validity period of the resolution. On April 14, 2026, the Company disclosed the "Announcement on Early Repayment of Temporarily Idle Raised Funds Used to Supplement Working Capital," stating that the Company had not used temporarily idle raised funds to supplement working capital. On April 24, 2026, the Company held its 14th meeting of the Second Board of Directors, which reviewed and approved the "Proposal on Using Part of the Temporarily Idle Raised Funds to Temporarily Supplement Working Capital." It was agreed that, under the premise of ensuring the funding needs of the investment projects, an amount not exceeding RMB 150 million (inclusive) of temporarily idle raised funds would be used to temporarily supplement working capital, limited to production and operation related to the main business. The usage period is 12 months from the date of the Board of Directors' approval, and the amount can be rolled over within the validity period of the resolution; on April 24, 2026